Concepedia

Lorna Bozeman

LB

Statistics

Publications

20

Citations

3.3K

H-Index

19

Active since

1981

Affiliations

Centers for Disease Control and Prevention(Current)

MUJHU Research Collaboration

Johns Hopkins Medicine

Case Western Reserve University

Johns Hopkins University

Lorna Bozeman is an author at Centers for Disease Control and Prevention specializing in tuberculosis care, infectious diseases, and pharmacotherapy.

Publications per year

1981–2020

20

Publications

20

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling, Margarita E. Villarino, Andrey Borisov et al. · New England Journal of Medicine · 2011 · 983 citations · Full text

, , +17

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Debra Benator, Mondira Bhattacharya, Lorna Bozeman et al. · The Lancet · 2002 · 411 citations

, , +14

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

Taraz Samandari, Tefera Agizew, Samba Nyirenda et al. · The Lancet · 2011 · 357 citations

, , +12

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid

Andrew Vernon, William J. Burman, Debra Benator et al. · The Lancet · 1999 · 310 citations

, , +15

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

Susan E. Dorman, John L. Johnson, Stefan Goldberg et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 266 citations

, , +14

1–5 of 20